Proprietary

Pipeline

Proprietary Pipeline

Therapeutic Approach Disease Drug Discovery Preclinical IND Phase 1 Phase 2 Phase 3
Anti Inflammatory Psoriasis exRP250
40% Complete
Asthma exRA
38% Complete
IBS exRI
38% Complete
Cardiac Fibrosis exRC
38% Complete
NAFLD exRL
38% Complete
PCOD exRP5
38% Complete
Alzheimer Disease exRAD
38% Complete
Polycystic Kidney Disease exRPK
38% Complete
Immuno Oncology Breast Cancer exRB
38% Complete
Therapeutic Approach Disease Drug Discovery Preclinical Phase 3
Ministry of Ayush Psoriasis VVPsoriasis Spray
100% Complete
DarkLight